Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Stroke genetics informs drug discovery and risk prediction across ancestries.
Nature. 2022 Nov;611(7934):115-123. doi: 10.1038/s41586-022-05165-3. Epub 2022 Sep 30.
Nature. 2022.
PMID: 36180795
Free PMC article.
Using a three-pronged approach(4), we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ance …
Using a three-pronged approach(4), we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VC …
FSH-blocking therapeutic for osteoporosis.
Gera S, Kuo TC, Gumerova AA, Korkmaz F, Sant D, DeMambro V, Sudha K, Padilla A, Prevot G, Munitz J, Teunissen A, van Leent MMT, Post TGJM, Fernandes JC, Netto J, Sultana F, Shelly E, Rojekar S, Kumar P, Cullen L, Chatterjee J, Pallapati A, Miyashita S, Kannangara H, Bhongade M, Sengupta P, Ievleva K, Muradova V, Batista R, Robinson C, Macdonald A, Hutchison S, Saxena M, Meseck M, Caminis J, Iqbal J, New MI, Ryu V, Kim SM, Cao JJ, Zaidi N, Fayad ZA, Lizneva D, Rosen CJ, Yuen T, Zaidi M.
Gera S, et al.
Elife. 2022 Sep 20;11:e78022. doi: 10.7554/eLife.78022.
Elife. 2022.
PMID: 36125123
Free PMC article.
Item in Clipboard
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
MacDonald S, Shah AS, Tousi B.
MacDonald S, et al.
Drugs Aging. 2022 Jul;39(7):505-522. doi: 10.1007/s40266-022-00939-w. Epub 2022 May 27.
Drugs Aging. 2022.
PMID: 35619045
Review.
There are currently no US Food and Drug Administration (FDA) approved drugs for the treatment of DLB, and there are only a few for PDD. ...
There are currently no US Food and Drug Administration (FDA) approved drugs for the treatment of DLB, and there are only a few for PD …
Item in Clipboard
G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model.
Huang Y, Rafael Guimarães T, Todd N, Ferguson C, Weiss KM, Stauffer FR, McDermott B, Hurtle BT, Saito T, Saido TC, MacDonald ML, Homanics GE, Thathiah A.
Huang Y, et al.
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2204828119. doi: 10.1073/pnas.2204828119. Epub 2022 Sep 26.
Proc Natl Acad Sci U S A. 2022.
PMID: 36161942
Free PMC article.
Biased G protein-coupled receptor (GPCR) ligands, which preferentially activate G protein or beta-arrestin signaling pathways, are leading to the development of drugs with superior efficacy and reduced side effects in heart disease, pain management, and neuropsychiatric di …
Biased G protein-coupled receptor (GPCR) ligands, which preferentially activate G protein or beta-arrestin signaling pathways, are leading t …
Item in Clipboard
Cite
Cite